K. Sugio

发表

The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors.

S. Akinaga, K. Muro, Y. Koh, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

A review of mechanism of action of steroid and non-steroid anti-inflammatory drugs

K. Ohuchi, S. Tsurufuji, K. Sugio, 1980 .

The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasone

S. Tsurufuji, K. Sugio, F. Takemasa, 1979, Nature.

Sodium‐glucose cotransporter 2 inhibitor luseogliflozin improves glycaemic control, assessed by continuous glucose monitoring, even on a low‐carbohydrate diet

R. Nishimura, H. Omiya, S. Sakai, 2016, Diabetes, obesity & metabolism.

Effects of luseogliflozin, a sodium–glucose co‐transporter 2 inhibitor, on 24‐h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double‐blind, placebo‐controlled, crossover study

R. Nishimura, H. Jinnouchi, H. Omiya, 2015, Diabetes, obesity & metabolism.

Separation of tubulin-binding and anti-inflammatory activity in colchicine analogs and congeners.

A. Brossi, P. Sharma, M. Maruyama, 1987, Life sciences.

The effect of CYP 2 C 19 polymorphism on the safety , tolerability , and pharmacokinetics of tivantinib ( ARQ 197 ) : results from a phase I trial in advanced solid tumors

S. Akinaga, K. Muro, Y. Koh, 2013 .

Suppression by dexamethasone of vascular permeability responses induced with leukotrienes C and D in the rat skin.

K. Ohuchi, S. Tsurufuji, K. Sugio, 1981, Prostaglandins.

Effects of forskolin and prostaglandin E1 on leukotriene C- and D-induced plasma exudation in the rat skin.

J. Daly, S. Tsurufuji, K. Sugio, 1986, Life sciences.

Inhibition of Inflammatory Action of Leukotriene C and D and PGE by Glucocorticoids

K. Ohuchi, S. Tsurufuji, K. Sugio, 1982 .

Blockade by antiglucocorticoids, actinomycin D and cycloheximide of anti-inflammatory action of dexamethasone against bradykinin.

S. Tsurufuji, K. Sugio, F. Takemasa, 1980, The Journal of pharmacology and experimental therapeutics.

MECHANISM OF ANTI‐INFLAMMATORY ACTION OF GLUCOCORTICOIDS: RE‐EVALUATION OF VASCULAR CONSTRICTION HYPOTHESIS

S. Tsurufuji, K. Sugio, 1981, British journal of pharmacology.

Comparative study between steroidal and nonsteroidal anti-inflammatory drugs on the mode of their actions on vascular permeability in rat carrageenin-air-pouch inflammation.

K. Ohuchi, S. Tsurufuji, M. Hashimoto, 1980, Journal of pharmacobio-dynamics.

Release of T‐kinin and bradykinin in carrageenin induced inflammation in the rat

A. Barlas, L. Greenbaum, K. Sugio, 1985, FEBS letters.

Vascular permeability responses and the role of prostaglandin E2 in an experimental allergic inflammation of air pouch type in rats

N. Hirasawa, K. Ohuchi, S. Tsurufuji, 1986, British journal of pharmacology.

Adenosine analogs: potentiation of bradykinin-induced plasma exudation in rat skin and prevention by caffeine and theophylline.

J. Daly, K. Sugio, 1984, Life sciences.

Effect of forskolin on alterations of vascular permeability induced with bradykinin, prostaglandin E1, adenosine, histamine and carrageenin in rats.

J. Daly, K. Sugio, 1983, Life sciences.

Effects of forskolin analogs, phosphodiesterase inhibitors and 8-bromo cyclic AMP on plasma exudations induced with bradykinin and prostaglandin E1 in rat skin.

J. Daly, K. Sugio, 1984, Life sciences.

Inhibition of vascular permeability by cycloheximide in granulomatous inflammation.

Y. Endo, S. Tsurufuji, K. Sugio, 1977, Biochemical pharmacology.

Increase in vascular permeability of rat and guinea pig skin by T-kinin

L. Greenbaum, K. Sugio, 1988, Inflammation.